Mycoses clinical trials
The registry lists 260 studies for Mycoses across more than 10 countries. 37 are recruiting or about to start. 117 of them are mainly about Mycoses (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 21 narrower conditions too, such as Onychomycosis: 1,312 studies, 189 open.
Get an email when these change. Save the Mycoses studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Merck Sharp & Dohme LLC (26) · National Institute of Allergy and Infectious Diseases (NIAID) (13) · Pfizer (10) · National Cancer Institute (NCI) (9) · Assiut University (8) · Basilea Pharmaceutica (8) · University of Pittsburgh (8) · Astellas Pharma Inc (5)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Nov 2026Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis · Phase 3 · Wooshin Labottach Co., Ltd.
- Dec 2026Large Algorithm Setting and Validation Study · Nanopath, Inc
- Dec 2026Diagnostics of Mycotic Sinusitis in ENT Patients · University Hospital Ostrava
- Dec 2026PK/PD of Caspofungin in Children Severe Infection · Children's Hospital of Fudan University
- Feb 2027A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis · Institute of Hematology & Blood Diseases Hospital, China
- Mar 2027Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota · Centre National de la Recherche Scientifique, France
- May 2027Fungal Vascular Graft Infections, French Multicenter Retrospective Study · University Hospital, Bordeaux
- Jun 2027Cryptococcosis Associated With Bruton Tyrosine Kinase Inhibitors · Assistance Publique - Hôpitaux de Paris
- Jul 2027Prospective Data Bank Creation to Study Vaginal Conditions · Texas Tech University Health Sciences Center
- Jul 2027Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors · Universitaire Ziekenhuizen KU Leuven
Who these studies take
Of the 24 Mycoses studies recruiting now, 13 (54%) set no upper age limit and 4 (17%) stop at 75 or younger. 5 (21%) take children under 18. 3 (13%) are for women only and 0 (0%) for men only; 6 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 5 (21%) | 5 (21%) |
| 18 | 22 (92%) | 20 (83%) |
| 30 | 22 (92%) | 19 (79%) |
| 40 | 22 (92%) | 19 (79%) |
| 50 | 21 (88%) | 19 (79%) |
| 65 | 21 (88%) | 19 (79%) |
| 75 | 21 (88%) | 19 (79%) |
| 85 | 18 (75%) | 17 (71%) |
Across all 260 studies, recruiting or not: 28% stop at 75 or younger and 23% at 65; 37% take children; 4% are for women only and 2% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Mycoses studies take
Of 18 phase 1 interventional studies under Mycoses, half reached primary completion within 8 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 8 mo3–13 · 18 studies | — | — |
| Phase 3 | 68 mo36–81 · 15 studies | — | — |
| Observational | 39 mo17–… · 28 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Newly registered1
- Cryptococcosis Associated With Bruton Tyrosine Kinase InhibitorsOct 19, 2026NCT07881055
Studies
Recruiting first, then most recently updated. Showing 50 of 260. Browse all 260 → or search them.
- Detection and Characterization of Infections and Infection SusceptibilityRecruitingNCT004045601 country
- Natural History of Individuals With Immune System Problems That Lead to Fungal InfectionsRecruitingNCT013864371 country
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.RecruitingNCT06925321Phase 315 countries
- Cryptococcosis Associated With Bruton Tyrosine Kinase InhibitorsNot yet recruitingNCT078810551 country
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.RecruitingNCT05421858Phase 320 countries
- Studies of Disorders With Increased Susceptibility to Fungal InfectionsRecruitingNCT012227411 country
- Rezafungin Prophylaxis in Liver TransplantEnrolling by invitationNCT06774144Phase 31 country
- A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of CareNot yet recruitingNCT07712484Phase 2
- Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical RelevanceRecruitingNCT077839711 country
- Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDSRecruitingNCT05814432Phase 31 country
- Large Algorithm Setting and Validation StudyRecruitingNCT076074701 country
- Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor ScoreRecruitingNCT076815831 country
- Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?RecruitingNCT019041881 country
- Emergency PWAS in Respiratory Infectious DiseaseRecruitingNCT053368511 country
- Pharmacogenomics for Better Treatment of Fungal Infections Clinical TrialRecruitingNCT06510699Phase 22 countries
- Impact of Internal Menstrual Protections on Immunity and Vaginal MicrobiotaRecruitingNCT071999981 country
- CD5CAR-NK Cells for Refractory Invasive Mold DiseaseNot yet recruitingNCT07454122Phase 11 country
- PK/PD of Caspofungin in Children Severe InfectionRecruitingNCT049615931 country
- Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised OutpatientsRecruitingNCT07110636Not applicable1 country
- Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, PsoriasisRecruitingNCT07029516Phase 31 country
- A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins ProphylaxisRecruitingNCT073570381 country
- Chest CT Scan in Pulmonary Mucormycosis: Prognostic ValueRecruitingNCT073398001 country
- Prospective Data Bank Creation to Study Vaginal ConditionsRecruitingNCT018292041 country
- Fungal Vascular Graft Infections, French Multicenter Retrospective StudyNot yet recruitingNCT071434091 country
- PTX3-targeted Antifungal ProphylaxisRecruitingNCT03828773Not applicable3 countries
- Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal InfectionsAvailableNCT06433128
- Isavuconazole in Critically Ill Patients: Efficacy and SafetyNot yet recruitingNCT07080359
- Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)Not yet recruitingNCT069697031 country
- Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell TransplantsRecruitingNCT03717623Phase 41 country
- Biobank of Samples From Patients With Infectious DiseasesNot yet recruitingNCT06722131
- Individualized First Maintenance Doses of Voriconazole Through a Multiparametric AlgorithmNot yet recruitingNCT06582186Phase 41 country
- Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant PatientsRecruitingNCT064983101 country
- Topical Application of Essential Oils to Treat OnchomycosisNot yet recruitingNCT06417983
- Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INORecruitingNCT060256821 country
- PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.Not yet recruitingNCT06220370
- The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University HospitalNot yet recruitingNCT05876962
- Diagnostics of Mycotic Sinusitis in ENT PatientsRecruitingNCT05955859Not applicable1 country
- A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of PhototoxicityCompletedNCT00353158Phase 11 country
- Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic InfectionsTerminatedNCT03159364Phase 1/21 country
- Fungal Infections During and After the SARS-CoV-2 Pandemic: A Retrospective ComparisonCompletedNCT064838151 country
- New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis PneumoniaCompletedNCT003425891 country
- Combination of Oral Antifungal Treatment for Refractory DermatophytosisCompletedNCT07816510Not applicable1 country
- Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South AfricaWithdrawnNCT05539989Phase 1/21 country
- Impact of Genotyping P450 2C19 on Hospitalization PeriodWithdrawnNCT03554239Not applicable
- Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)CompletedNCT02154178Not applicable1 country
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 39 countries
- An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal InfectionCompletedNCT052023661 country
- Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk FactorsActive, not recruitingNCT072381141 country
- COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)CompletedNCT048188531 country
- Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare MoldsTerminatedNCT04240886Phase 24 countries